Leroux-Roels G - Search Results

1

Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02(A) candidate tuberculosis vaccine in purified protein derivative-negative adults.

Leroux-Roels I, Leroux-Roels G, Ofori-Anyinam O, Moris P, De Kock E, Clement F, Dubois MC, Koutsoukos M, Demoitié MA, Cohen J, Ballou WR. Leroux-Roels I, et al. Clin Vaccine Immunol. 2010 Nov;17(11):1763-71. doi: 10.1128/CVI.00133-10. Epub 2010 Sep 22. Clin Vaccine Immunol. 2010. PMID: 20861328 Free PMC article. Clinical Trial.

2

Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.

Leroux-Roels G, Van Hecke E, Michielsen W, Voet P, Hauser P, Pêtre J. Leroux-Roels G, et al. Vaccine. 1994 Jul;12(9):812-8. doi: 10.1016/0264-410x(94)90290-9. Vaccine. 1994. PMID: 7975860 Clinical Trial.

3

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults.

Leroux-Roels G, Desombere I, De Tollenaere G, Petit MA, Desmons P, Hauser P, Delem A, De Grave D, Safary A. Leroux-Roels G, et al. Vaccine. 1997 Nov;15(16):1724-31. doi: 10.1016/s0264-410x(97)00117-5. Vaccine. 1997. PMID: 9364674 Clinical Trial.

4

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 2. Immunogenicity in poor responders to hepatitis B vaccines.

Leroux-Roels G, Desombere I, Cobbaut L, Petit MA, Desmons P, Hauser P, Delem A, De Grave D, Safary A. Leroux-Roels G, et al. Vaccine. 1997 Nov;15(16):1732-6. doi: 10.1016/s0264-410x(97)00118-7. Vaccine. 1997. PMID: 9364675 Clinical Trial.

5

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system.

Thoelen S, Van Damme P, Mathei C, Leroux-Roels G, Desombere I, Safary A, Vandepapeliere P, Slaoui M, Meheus A. Thoelen S, et al. Vaccine. 1998 Apr;16(7):708-14. doi: 10.1016/s0264-410x(97)00254-5. Vaccine. 1998. PMID: 9562690 Clinical Trial.

6

The first combined vaccine against hepatitis A and B: an overview.

Thoelen S, Van Damme P, Leentvaar-Kuypers A, Leroux-Roels G, Bruguera M, Frei PC, Bakasenas V, Safary A. Thoelen S, et al. Vaccine. 1999 Mar 26;17(13-14):1657-62. doi: 10.1016/s0264-410x(98)00421-6. Vaccine. 1999. PMID: 10194819

7

A comparison of two commercial recombinant vaccines for hepatitis B in adolescents.

Leroux-Roels G, Abraham B, Fourneau M, De Clercq N, Safary A. Leroux-Roels G, et al. Vaccine. 2000 Nov 22;19(7-8):937-42. doi: 10.1016/s0264-410x(00)00217-6. Vaccine. 2000. PMID: 11115719 Clinical Trial.

8

The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population.

Jacques P, Moens G, Desombere I, Dewijngaert J, Leroux-Roels G, Wettendorff M, Thoelen S. Jacques P, et al. Vaccine. 2002 Nov 1;20(31-32):3644-9. doi: 10.1016/s0264-410x(02)00397-3. Vaccine. 2002. PMID: 12399191 Clinical Trial.

9

Evaluation of a new rapid test for the combined detection of hepatitis B virus surface antigen and hepatitis B virus e antigen.

Clement F, Dewint P, Leroux-Roels G. Clement F, et al. J Clin Microbiol. 2002 Dec;40(12):4603-6. doi: 10.1128/JCM.40.12.4603-4606.2002. J Clin Microbiol. 2002. PMID: 12454159 Free PMC article.

10

A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers.

Leroux-Roels G, Depla E, Hulstaert F, Tobback L, Dincq S, Desmet J, Desombere I, Maertens G. Leroux-Roels G, et al. Vaccine. 2004 Aug 13;22(23-24):3080-6. doi: 10.1016/j.vaccine.2004.02.002. Vaccine. 2004. PMID: 15297058 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters